In glioblastoma (GBM) and lower-grade gliomas (LGG), Zhao et al. demonstrated that LINC00466 acts as a competitive endogenous RNA (ceRNA), suppressing miR-137 and thereby increasing PHI-1 expression, which is linked to temozolomide resistance [40]. The gene discussed is PPP1R14B; the disease is glioblastoma.